Regulus Therapeutics Inc. buy HC Wainwright
Start price
06.05.24
/
50%
€2.26
Target price
06.05.25
€8.35
Performance (%)
-26.11%
Price
04.07.24
€1.65
Summary
This prediction is currently active. The prediction for Regulus Therapeutics Inc. disappoints with a performance of -26.11%. This prediction currently runs until 06.05.25. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Regulus Therapeutics Inc. | -13.830% | -13.830% |
iShares Core DAX® | 1.133% | -0.156% |
iShares Nasdaq 100 | 0.815% | 8.801% |
iShares Nikkei 225® | 1.990% | 3.286% |
iShares S&P 500 | -0.014% | 5.438% |
Comments by HC_Wainwright for this prediction
In the thread Regulus Therapeutics Inc. diskutieren
Regulus Therapeutics Inc. (NASDAQ: RGLS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
Ratings data for RGLS provided by MarketBeat
Stopped prediction by HC_Wainwright for Regulus Therapeutics Inc.
Regulus Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.86
25.06.24
25.06.24
€9.34
25.06.25
25.06.25
-10.22%
04.07.24
04.07.24
Regulus Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.64
25.03.24
25.03.24
€8.30
25.03.25
25.03.25
-36.74%
04.07.24
04.07.24
Regulus Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.50
19.09.23
19.09.23
€8.41
19.09.24
19.09.24
10.00%
04.07.24
04.07.24